Innocan Pharma Corp (INNO.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 10 | 10 | 10 | 10 | 22 |
| Accounts receivable | 854 | -393 | 60 | -93 | -396 |
| Accounts payable and accrued liabilities | 95 | 312 | 166 | -73 | N/A |
| Other Working Capital | 737 | -600 | 503 | -166 | -404 |
| Other Operating Activity | -2,178 | -903 | -1,501 | -547 | -270 |
| Operating Cash Flow | $-482 | $-1,574 | $-762 | $-869 | $-1,048 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | 0 | 0 | 0 | 10 |
| Investing Cash Flow | $0 | $0 | $0 | $0 | $10 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -10 | -10 | -10 | -9 | N/A |
| Common Stock Issued | 545 | 58 | 3,017 | 4 | 242 |
| Other Financing Activity | 424 | 0 | 15 | 0 | -38 |
| Financing Cash Flow | $959 | $48 | $3,022 | $-5 | $204 |
| Exchange Rate Effect | 74 | 10 | 16 | -72 | N/A |
| Beginning Cash Position | 1,787 | 3,303 | 1,027 | 1,973 | 2,778 |
| End Cash Position | 2,338 | 1,787 | 3,303 | 1,027 | 1,973 |
| Net Cash Flow | $477 | $-1,526 | $2,260 | $-874 | $-834 |
| Free Cash Flow | |||||
| Operating Cash Flow | -482 | -1,574 | -762 | -869 | -1,048 |
| Free Cash Flow | -482 | -1,574 | -762 | -869 | -1,048 |